BASF Fine Chemicals Generic Drug Formulations 1998
1.6 Stability data
It is only in exceptional cases or when certain groups of active substances
are present that data are given on the chemical and or the physical stability
of the formulations. The reasons are as follows.
a. The formulations are practically always modified by the customer
when they are scaled up to meet the demands of industry.
b. Aromas or colorants are added to the formulations in amounts
depending on the particular taste of the target group.
c. In view of the very number of for- mulations presented here and for
capacity reasons, the long-term stability of all of them cannot be
checked.
The stability of the preparation may change as a result of items a. and b.
Thus the final formulation must be checked in any event.
Data on the chemical stability are often available for sensitive materials,
e. g. PVP-iodine or vitamins. They mostly concern either storage at
room temperature 20 – 25 °C over a period of one year or a stress test
that lasts at least just as long.
In a number of formulations, data are also listed on the physical stability.
2 Tablets
2.1 Size of formulations and measured values
The formulations were developed on a laboratory scale in which case
200 –1,000 g of the mixtures to be tabletted were used. Normally, the
amounts weighed out in the formula- tions correspond to the amount in the
tablets multiplied by a factor of 1,000. The weight, hardness, disintegration,
and chipping of the tablets and the data on their release are measured
values.
2.2 Direct compression
The technology involved in direct compression assumes great impor-
tance in the tablet formulations, be- cause it is often the cheapest means,
particularly in the production of ge- nerics, that the active substance per-
mits. The limiting factors are the physical properties of the active sub-
stance and its concentration in the tablets cf. Chapter 2.5. Even sub-
stances such as ascorbic acid that are hardly suitable for direct tabletting
owing to the friability of their crystals can normally be directly pressed into
tablets at concentrations of 30 – 40 . However, this technique is not as
suitable if the content of ascorbic ac- id is higher. This limit may be shifted
upwards by special direct compres- sion auxiliaries, e. g. Ludipress. Two
important alternatives, viz. Ludipress and Kollidon VA 64, can be found in
the BASF line of pharmaceutical exci- pients for direct compression.
A. Ludipress Ludipress is a speciality derived from
lactose, Kollidon 30, and Kollidon CL. It thus combines the properties of a
filler, binder, disintegrant, and flowability agent and also often acts
as a release accelerator. By virtue of its versatility formulations containing it
are usually very simple. It can also be combined with almost all active sub-
stances with the exception of those that enter into a chemical interaction
with lactose Maillard reaction.
Active substances, e. g. many anal- getics, behave very differently with
Ludipress when the dosage is ex- tremely high. Acetylsalicylic acid and
metamizole can be pressed when lit- tle Ludipress has been added; ibu-
profen requires a larger amount; and the fraction of Ludipress required in
the tablets is too large for paraceta- mol = acetaminophen.
B. Kollidon VA 64 An alternative to Ludipress is the out-
standing dry binder Kollidon VA 64 together with excipients, e. g. calcium
phosphate, microcrystalline cellulose, lactose, or starch, and a disintegrant,
e. g. Kollidon CL. This combination even allows 500 mg of paracetamol
to be pressed into good tablets with a weight of 700 mg.
No other dry binder has a binding power and plasticity comparable to
those of Kollidon VA 64. Plasticity, in particular, is an important parameter
in direct compression. As can be seen in Fig. 1, this property of Kolli-
don VA 64 is not adversely effected by increasing the pressure. The bene-
ficial properties of Kollidon VA 64 can
BASF Fine Chemicals Generic Drug Formulations 1998
BASF Fine Chemicals Generic Drug Formulations 1998
also be exploited for the production of concentrated active substance that is
subsequently used for direct tabletting.
Obviously, Kollidon VA 64 and Ludi- press can also be combined with one
another.
2.3 Wet granulation